![Medicina | Free Full-Text | Overview and New Insights into the Metabolic Syndrome: Risk Factors and Emerging Variables in the Development of Type 2 Diabetes and Cerebrocardiovascular Disease Medicina | Free Full-Text | Overview and New Insights into the Metabolic Syndrome: Risk Factors and Emerging Variables in the Development of Type 2 Diabetes and Cerebrocardiovascular Disease](https://pub.mdpi-res.com/medicina/medicina-59-00561/article_deploy/html/images/medicina-59-00561-g012.png?1678766610)
Medicina | Free Full-Text | Overview and New Insights into the Metabolic Syndrome: Risk Factors and Emerging Variables in the Development of Type 2 Diabetes and Cerebrocardiovascular Disease
The co-existence of elevated high sensitivity C-reactive protein and homocysteine levels is associated with increased risk of metabolic syndrome: A 6-year follow-up study | PLOS ONE
![Methods of detecting atherosclerosis in non-cardiac surgical patients; the role of biochemical markers - ScienceDirect Methods of detecting atherosclerosis in non-cardiac surgical patients; the role of biochemical markers - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0007091217353230-gr1.jpg)
Methods of detecting atherosclerosis in non-cardiac surgical patients; the role of biochemical markers - ScienceDirect
![High-Risk Atherosclerosis and Metabolic Phenotype: The Roles of Ectopic Adiposity, Atherogenic Dyslipidemia, and Inflammation | Metabolic Syndrome and Related Disorders High-Risk Atherosclerosis and Metabolic Phenotype: The Roles of Ectopic Adiposity, Atherogenic Dyslipidemia, and Inflammation | Metabolic Syndrome and Related Disorders](https://www.liebertpub.com/cms/10.1089/met.2019.0115/asset/images/medium/met.2019.0115_figure1.jpg)
High-Risk Atherosclerosis and Metabolic Phenotype: The Roles of Ectopic Adiposity, Atherogenic Dyslipidemia, and Inflammation | Metabolic Syndrome and Related Disorders
![Targeting inflammation in atherosclerosis — from experimental insights to the clinic | Nature Reviews Drug Discovery Targeting inflammation in atherosclerosis — from experimental insights to the clinic | Nature Reviews Drug Discovery](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41573-021-00198-1/MediaObjects/41573_2021_198_Fig1_HTML.png)
Targeting inflammation in atherosclerosis — from experimental insights to the clinic | Nature Reviews Drug Discovery
![Frontiers | Hyperhomocysteinemia as a Risk Factor and Potential Nutraceutical Target for Certain Pathologies Frontiers | Hyperhomocysteinemia as a Risk Factor and Potential Nutraceutical Target for Certain Pathologies](https://www.frontiersin.org/files/Articles/437567/fnut-06-00049-HTML/image_m/fnut-06-00049-g001.jpg)
Frontiers | Hyperhomocysteinemia as a Risk Factor and Potential Nutraceutical Target for Certain Pathologies
![Homocysteine metabolism as the target for predictive medical approach, disease prevention, prognosis, and treatments tailored to the person | SpringerLink Homocysteine metabolism as the target for predictive medical approach, disease prevention, prognosis, and treatments tailored to the person | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs13167-021-00263-0/MediaObjects/13167_2021_263_Fig1_HTML.png)
Homocysteine metabolism as the target for predictive medical approach, disease prevention, prognosis, and treatments tailored to the person | SpringerLink
![The association between metabolic syndrome components and the development of atherosclerosis | Journal of Human Hypertension The association between metabolic syndrome components and the development of atherosclerosis | Journal of Human Hypertension](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41371-019-0273-0/MediaObjects/41371_2019_273_Fig1_HTML.png)
The association between metabolic syndrome components and the development of atherosclerosis | Journal of Human Hypertension
![Frontiers | Pathophysiology of Circulating Biomarkers and Relationship With Vascular Aging: A Review of the Literature From VascAgeNet Group on Circulating Biomarkers, European Cooperation in Science and Technology Action 18216 Frontiers | Pathophysiology of Circulating Biomarkers and Relationship With Vascular Aging: A Review of the Literature From VascAgeNet Group on Circulating Biomarkers, European Cooperation in Science and Technology Action 18216](https://www.frontiersin.org/files/Articles/789690/fphys-12-789690-HTML-r1/image_m/fphys-12-789690-g001.jpg)
Frontiers | Pathophysiology of Circulating Biomarkers and Relationship With Vascular Aging: A Review of the Literature From VascAgeNet Group on Circulating Biomarkers, European Cooperation in Science and Technology Action 18216
![PDF] The importance of homocysteine in the development of cardiovascular complications in patients with rheumatoid arthritis | Semantic Scholar PDF] The importance of homocysteine in the development of cardiovascular complications in patients with rheumatoid arthritis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/4b742ec9d2d9933d24456a8a18cabd8b55073b91/2-Figure1-1.png)
PDF] The importance of homocysteine in the development of cardiovascular complications in patients with rheumatoid arthritis | Semantic Scholar
![Risk Factors for Coronary Artery Disease: Practice Essentials, Risk Factor Biomarkers, Conventional Risk Factors Risk Factors for Coronary Artery Disease: Practice Essentials, Risk Factor Biomarkers, Conventional Risk Factors](https://img.medscapestatic.com/pi/meds/ckb/92/9592tn.jpg)
Risk Factors for Coronary Artery Disease: Practice Essentials, Risk Factor Biomarkers, Conventional Risk Factors
![Hyperhomocysteinemia is an independent risk factor of atherosclerosis in patients with metabolic syndrome | Diabetology & Metabolic Syndrome | Full Text Hyperhomocysteinemia is an independent risk factor of atherosclerosis in patients with metabolic syndrome | Diabetology & Metabolic Syndrome | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13098-019-0484-0/MediaObjects/13098_2019_484_Fig1_HTML.png)
Hyperhomocysteinemia is an independent risk factor of atherosclerosis in patients with metabolic syndrome | Diabetology & Metabolic Syndrome | Full Text
![Homocysteine – from disease biomarker to disease prevention - Smith - 2021 - Journal of Internal Medicine - Wiley Online Library Homocysteine – from disease biomarker to disease prevention - Smith - 2021 - Journal of Internal Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/6937c53b-06c7-408d-a739-dfcc56d7b986/joim13279-toc-0001-m.jpg)